Cogent Biosciences - Stock Price History | COGT

Historical daily share price chart and data for Cogent Biosciences since 2021 adjusted for splits. The latest closing stock price for Cogent Biosciences as of September 27, 2021 is 8.74.
  • The all-time high Cogent Biosciences stock closing price was 67.08 on July 31, 2018.
  • The Cogent Biosciences 52-week high stock price is 14.44, which is 65.2% above the current share price.
  • The Cogent Biosciences 52-week low stock price is 5.83, which is 33.3% below the current share price.
  • The average Cogent Biosciences stock price for the last 52 weeks is 9.19.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Cogent Biosciences Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 6.5597 2.8860 13.2800 1.2800 11.2300 289.82%
2019 10.5659 17.8800 19.7200 2.0400 2.8808 -83.63%
2018 44.6912 44.4400 67.0800 14.8000 17.6000 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.348B $0.008B
Cogent Biosciences Inc. is a biotechnology company. It is focused on developing precision therapies for genetically defined diseases. The company's program consist PLX9486. Cogent Biosciences Inc., formerly known as Unum Therapeutics Inc., is based in CAMBRIDGE, Mass.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29